References
- Gordo-Vidal F, Enciso-Calderón V. Síndrome de distrés respiratorio agudo, ventilación mecánica y función ventricular derecha [Acute respiratory distress syndrome, mechanical ventilation and right ventricular function]. Med Intensiva 2012;36(2):138–42.
- Gorman EA, O’Kane CM, McAuley DF. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet. (2022) 1; 400(10358):1157–70.
- Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomized controlled trial. Lancet Respiratory Medicine. 2018;6(9): 691–8.
- WeVent. Protocolo respiratorio de pacientes con SARS-CoV-2 (COVID-19). Disponible en: https://www.formacionsanitaria.eu/index.php/es/wevent?fbclid=IwAR3-v_7JY2K9IRInVOEIMy1uC5Lb28fML72Dsnrlt_eFHCRDHt1s5jZEmNY.
- Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes?. Intensive care medicine. 2020;46: 1099–1102.
- Bos L, Paulus F, Vlaar A, et al. Subphenotyping ARDS in COVID-19 Patients: Consequences for Ventilator Management. Annals ATS. (2020).
- Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Critical Care 2020;24(1):1–3.
- Rello J, Storti E, Belliato M, et al. Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers. European Respiratory Journal. 2020;55(5): 1–4.
- Robba C, Battaglini D, Ball L, et al. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19, Respiratory Physiology and neurobiology. 2020;279:103455
- Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788–800.
- Sinha P, Calfee CS, Cherian S, et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. Lancet Respiratory Medicine. 2020;8(12):1209–18.
- Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. COVID-19 Spanish ICU Network. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 2020;46:2200–11.
- COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47:60–73
- Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA 2020;180(7):934–43.
- Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382(18):1708–1720.
- Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395(10223):497–506.
- Chen T, Wu D, Chen H, Yan W, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091
- Reyes LF, Bastidas A, Narváez PO, et al. Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study. PloS One. 2022;17(3):e0265529.
- Chand S, Kapoor S, Orsi D, et al. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center. J Intensive Care Med 2020; 35(10):963–970.
- Friedman AN, Guirguis J, Kapoor R, et al. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021; 29(10):1719–30.
- Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PloS one 2021;16(2):e0245772
- Cueto-Manzano AM, Espinel-Bermúdez MC, Hernández-González SO, et al. Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study. BMJ 2021;11(7):e050321.
- Ramírez P, Gordón M, Martín-Cerezuela M, et al. Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain. Medicina Intensiva 2021;45(1):27–34.
- Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021;12(7):1026–1041.
- Ejaz H, Alsrhani A, Zafar A, at el. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–39.
- COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. The Lancet; 2022. 399(10334):1513–36.
- Singh H, Dahiya N, Yadav M, et al. Emergence of SARS-CoV-2 New Variants and Their Clinical Significance. Canadian Journal Infectious Diseases Medical Microbiology. 2022;2022:7336309.
- Saavedra-López MA, Calle-Ramirez XM, Hernández RM. Latin American authorship in scientific production on COVID-19. Rev Esp Enferm Dig 2021;113(2):147.
- Naffeti B, Bourdin S, Ben Aribi W, et al. Spatio-temporal evolution of the COVID-19 across African countries. Frontiers in Public Health 2022;10:1039925.
- Islas Cerón RG, Valencia Ortíz AI, Bustos Vázquez E, et al. Asociación entre calidad de atención y el nivel de saturación del servicio de urgencias de un hospital de Hidalgo, México. Journal of Negative and No Positive Results 2020;5(10):1163–78.
- Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules 2020;26(1):39.
- IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp
- Dahiru T. P - value, a true test of statistical significance? A cautionary note. Annls of Ibadan postgraduate medicina. 2008;6(1):21–6.
- Campos-Nonato I, Galván-Valencia Ó, Hernández-Barrera L, et al. Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la Ensanut 2022. Salud Publica Mex. 2023;65:238–47.
- Bórquez-López YF, Monares-Zepeda E, Franco-Granillo J, et al. Síndrome de dificultad respiratoria vs síndrome de dificultad respiratoria por COVID-19: las diferencias que realmente importan. Medicina crítica (Colegio Mexicano de Medicina Crítica). 2021;35(4):176–81.
- Torrelles JB, Restrepo BI, Bai Y, Ross C, Schlesinger LS, Turner J. (2022). The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections. Front. Aging. 3:818700.
- López-Simarro F, Redondo Margüello E, Mediavilla Bravo JJ, et al. Prevención y tratamiento de la enfermedad infecciosa en personas con diabetes. Medicina de familia SEMERGEN 2019;45(2):117–27.
- Ejaz H, Alsrhani A, Zafar A, et al. Deleterious impact on infected patients. J Infect Public Health 2020;13(12):1833–39.
- Pérez-Abeledo M, Sanz Moreno JC. Variantes de SARS-CoV-2, una historia todavía inacabada [SARS-CoV-2 variants, a still unfinished story]. Vacunas 2021;22(3):173–79
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA; 2020;323(20):2052–59.
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Medicine 2020;8(5):475–81.
- Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061–69.
- Lim ZJ, Subramaniam A, Ponnapa Reddy M, et al. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. American journal of respiratory and critical care medicine 2021;203(1):54–66.
- Papazian L, Aubron C, Brochard L, et al. Formal guidelines: management of acute respiratory distress syndrome. Annals of Intensive Care 2019;9(1):69.
- Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Medicine 2020; 46(12):2200–11.
- Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. New England Journal Medicine 1998; 338(6):347–54.
- Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. New England Journal Medicine 2015; 372(8):747–55.
- Namendys-Silva SA. ECMO for ARDS due to COVID-19. Heart Lung. The Journal of Cardiopulmonary and Acute Care 2020;49(4):348–49.
- Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19 associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respiratory Medicine 2020;8(12):1201–08.